Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.27
-0.04 (-0.55%)
Apr 29, 2026, 9:31 AM EDT - Market open

Kezar Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-56.03-83.74-101.87-68.24-54.63
Upgrade
Depreciation & Amortization
0.91.041.071.021.51
Upgrade
Other Amortization
0.180.260.240.210.09
Upgrade
Loss (Gain) From Sale of Assets
0.290.010--
Upgrade
Asset Writedown & Restructuring Costs
0.911.552.91--
Upgrade
Loss (Gain) From Sale of Investments
-2-5.04-6.83-1.41.77
Upgrade
Stock-Based Compensation
8.9613.0118.1414.017.6
Upgrade
Other Operating Activities
0.43--0.01-
Upgrade
Change in Accounts Payable
-7.34-3.156.351.811.22
Upgrade
Change in Other Net Operating Assets
1.941.85-1.64-6.270.01
Upgrade
Operating Cash Flow
-51.78-74.21-81.65-58.85-42.44
Upgrade
Capital Expenditures
-0.01-0.03-1.81-1.58-0.32
Upgrade
Sale of Property, Plant & Equipment
0.12-0.01--
Upgrade
Investment in Securities
92.3580.4677.85-89.81-28.13
Upgrade
Investing Cash Flow
92.4680.4376.05-91.39-28.44
Upgrade
Long-Term Debt Issued
----9.53
Upgrade
Long-Term Debt Repaid
-10.65----
Upgrade
Net Debt Issued (Repaid)
-10.65---9.53
Upgrade
Issuance of Common Stock
0.070.10.64127.86103.05
Upgrade
Financing Cash Flow
-10.590.10.64127.86112.59
Upgrade
Foreign Exchange Rate Adjustments
0.03-0.06-0-0.05-0.05
Upgrade
Net Cash Flow
30.136.26-4.96-22.4341.65
Upgrade
Free Cash Flow
-51.79-74.24-83.46-60.42-42.75
Upgrade
Free Cash Flow Margin
---1192.21%--
Upgrade
Free Cash Flow Per Share
-7.08-10.18-11.50-8.97-8.10
Upgrade
Cash Interest Paid
0.771.341.320.970.07
Upgrade
Levered Free Cash Flow
-29.15-45.24-39.26-36-22.7
Upgrade
Unlevered Free Cash Flow
-28.77-44.5-38.5-35.47-22.69
Upgrade
Change in Working Capital
-5.4-1.34.71-4.461.23
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.